Provision of Metformin and Placebo for Clinical Trial

The trust was successful in obtaining a grant from NIHR for a clinical trial to look at the use of metformin in people newly diagnosed with psychosis. The clinical trial (including the recruitment phase) is estimated to take place between June 2026 to November 2028. As part of that grant we need to source a supplier that has the capability to purchase or manufacture Metformin and an identical placebo for a clinical trial, to package and label both to our requirements and distribute to Trusts across the UK in a predetermined schedule.